ADORA2A and Alzheimer disease: Considering previous converging studies in different models of AD (Orr et al., 2015, 2018; Laurent et al., 2016; Viana da Silva et al., 2016; Silva et al., 2018), the present findings further highlight A2AR as a promising therapeutic target in AD.